Over the past decade, single-cell RNA sequencing (scRNA-seq) has transformed biological research, uncovering groundbreaking insights—from the diversity of cell types in the brain to drug-resistant cancer states and previously unknown immune cell functions. As this technology advances, generating large-scale datasets has become faster and more affordable. However, analyzing these massive datasets demands computational methods that can handle their growing complexity.
Currently, most scRNA-seq analyses start with principal component analysis (PCA), followed by nonlinear dimensionality reduction techniques like t-SNE or UMAP to visualize data in 2D. Clustering algorithms such as Louvain or Leiden then identify cell types. But these methods have a major drawback: compressing high-dimensional data into two dimensions can distort biological signals, sometimes leading to conflicting interpretations of similar datasets.
While neural network-based models (like variational autoencoders and transformers) offer scalability, their nonlinearity often produces hard-to-interpret results and risks overfitting. Recent benchmarks even suggest that simpler models sometimes outperform these advanced approaches.
Continue reading to support muhammad-imran-ali
Sign in or create an account to access the full narrative and engage with the community.
- Read unlimited public publications
- Directly support independent journalists & authors
- Join discussion threads and leave reactions
Responses (0)
Sign in to share your thoughts.
Sign in